Riskpilot← Back to searchSign inGet full accessHemcare Oy
OYActiveY-tunnus 2542363-2Merivirta 3-AOther social work activities without accommodation n.e.c. · NACE 8899Est. 2013— employees
Revenue 2025
EUR 11,1M
-61% vs 2023
EBITDA margin
13.9%
-52% vs 2023
Equity ratio
77.0%
Financial strength
Net profit 2025
EUR 1,2M
-52% vs 2023
| Revenue | EUR 11,1M | -61% |
| EBITDA | EUR 1,6M | -52% |
| Net profit | EUR 1,2M | -52% |
| Total assets | EUR 1,6M | -73% |
| Equity | EUR 1,2M | -52% |
| Employees | — | — |
Legal name
Hemcare Oy
Y-tunnus number
2542363-2
Legal form
Osakeyhtiö
NACE code
8899 · Other social work activities without accommodation n.e.c.
Founded
8. huhtikuuta 2013
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Sosiaali- ja terveyspalvelut ja niitä tukevat toiminnat sekä alan koulutus, konsultointi ja työnohjaus. Yhtiö voi omistaa, vuokarata ja hallita osakkeita ja kiinteistöjä Suomessa ulkomailla.
Address
Merivirta 3-A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 196 | 0 | 9 044 | 28 333 | 11 139 |
| Staff expenses | −339 | −2 | −1 873 | −5 822 | −2 797 |
| EBITDA | −3 | −11 | 690 | 3 226 | 1 552 |
| Depreciation & amort. | — | — | — | −0 | −4 |
| EBIT | −3 | −11 | 690 | 3 226 | 1 549 |
| Net financials | −3 | −0 | −2 | −3 | 1 |
| Profit before tax | −6 | −12 | 688 | 3 223 | 1 549 |
| Tax | −0 | 55 | 106 | 649 | 312 |
| Net profit | −6 | −67 | 581 | 2 574 | 1 237 |
| Item | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|
| Total assets | 280 | 40 | 6 820 | 6 071 | 1 618 |
| Equity | 57 | −10 | 591 | 2 609 | 1 246 |
| Long-term debt | — | 0 | — | 0 | 1 |
| Short-term debt | 225 | 51 | 6 229 | 3 462 | 371 |
| Total debt | 225 | 51 | 6 229 | 3 462 | 372 |
EBITDA margin
13.9%
This company
15.8%
Market median
-12% vs market
20202025
Equity ratio
77.0%
This company
38.2%
Market median
+102% vs market
20202025
Return on equity
99.3%
This company
18.4%
Market median
+440% vs market
20202025
Net profit margin
11.1%
This company
8.1%
Market median
+37% vs market
20202025
Asset turnover
6.88×
This company
1.12×
Market median
+514% vs market
20202025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20202025
- Annual report 2025Filed via PRH / YTJ · Period 2024-01-01 – 2025-06-30
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2019-07-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MA Chief Executive Officer | Chief Executive Officer | 2015 |
| Former (1) | ||
SJ Audit | Audit | 2013 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2015 | |
| Chairperson | 2015 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 60% | 60% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tresvista Oy
Hemcare Oy Board members of Hemcare Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sari Johanna Gråsten | Audit | 0 companies |
| Mika Antero Okkonen | Chief Executive Officer | 0 companies |
| Jaana-Maija Raatikainen | Board of Directors | 0 companies |
| Tapani Antero Raatikainen | Chairperson | 0 companies |